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ABSTRACT
BACKGROUND
Oral cancer is the most common malignancy of head and neck
region its ranking 6th position of all malignancy. The most
commonly occuring sites are tongue, buccal mucosa, floor of the
mouth, lip and gingiva. Smoking tobacco and pan chewing are the
etiological factor for the occurence of oral squamous cell
carcinoma. Inhibition or imbalance of apoptosis or programmed cell
death leads to cancer. Two pathways are involved in apoptosis 1.
Intrinsic or mitochondrial pathway 2. Extrinsic pathway. Caspase -3
enzymes or involved in the apoptosis.
AIM
To Study the Immunohistochemical expression of caspase -3 in
oral squamous cell carcinoma.
MATERIALS AND METHODS
In our present study, totally 25 samples were included to
detect immunohistochemical expression of caspase-3. Twenty,
formalin fixed, paraffin embedded wax tissues histopathologically
diagonsed oral squamous cell carcinoma were included as case
(group I). Five normal buccal and gingival tissue formalin fixed,
paraffin embedded wax tissues included as cont rol (groupII).
Tissues were sectioned 0.5micron thickness and stained with
caspase-3 antibody.  The results were obtained and statistically
analyzed by using Mann-Whitney test .
RESULTS
Increased expression of caspase-3 was seen in epithelium and
connective tissue of oral squamous cell carcinoma tissue. In most of
the normal mucosa expression of caspase -3 was absent.  The p value
for epithelium and connective tissue was p<0.008 and p<0.016
respectively which was highly significant.
CONCLUSION
The results of our  present study demonstrated that increased
caspase-3expression was seen in oral  squamous cell carcinoma
tissues  than that of the normal mucosa.  These findings indicate the
caspase-3 expression response to prognosis of   the cancer and this
has to be explored in a larger sample for further studies.
KEY WORDS
Apoptosis, Caspase-3, Oral cancer.
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INTRODUCTION
Oral squamous cell carcinoma (OSCC) is the most frequent oral
malignancy of head & neck accounting for 90% of all malignancies, [ 1 ,
2 ] and often present a clinical diagnostic challenge, part icularly in its
early stages of development.  The incidence of OSCC differs widely in
various parts of the world, and ranges from 2 -10 per 1, 00,000 in a
year.
The South Asian countries such as Srilanka, India, Pakistan and
Bangladesh have shown a high incidence rate (3 ,  4 ) .  Despite advances in
prevention, diagnosis, and treatment, the 5 -year survival rate has not
improved over the past 30 years. [ 5 ] Surveys in India have shown that
about 80% of oral carcinomas are preceded by oral potentially
malignant oral disorders, most often, persistent leukoplakia (the most
common potentially malignant lesion of the oral  mucosa or oral sub
mucous fibrosis (OSMF), which predominantly affects the people of
South-East  origin . (6 )
The most common causes for the development of oral Squamous
cell carcinoma were use of tobacco or betel quid and the regular
consumption of alcoholic beverages. Infection of human papil lomavirus
(HPV) geno-types, and person eating less amount of fresh fruits and
vegetables were also causative of occurence of oral Squamous cell
carcinoma [ 7 ,8 ] .  The mutagenic effects of tobacco, alcohol, betel quid
or areca-nut are dependent upon dose,  frequency and duration of use,
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and are accelerated   by the concurrent use of two or more of these
agents [ 8 ] .
Compare to women men were most commonly affected by oral
squamous cell carcinoma because of high risk habits . The probability
of developing oral Squamous cell carcinoma increases with the period
of exposure to risk factors, and increasing age which adds the further
dimension of age-related mutagenic and epigenetic changes.
The ventral surface of the tongue and the floor of the mouth are
the most common sites affected by squamous cell carcinoma because
they are lined by thin non-keratinized epithelium.  Carcinogens readily
penetrate this thin epithelium to reach the progenitor cell compartment,
as well as carcinogens such as tobacco products and alcohol in
solution, constantly accumulate in the floor of the mouth and bathe the
tissues of the floor of the mouth and the ventral aspect of tongue [ 9 ] .
The stage of advancement of oral Squamous cell carcinoma at the time
of diagnosis is the most important prognostic factor [ 1 0 ] .
Oral Squamous cell carcinoma is most frequently diagnosed late
in the course of the disease because affected persons fail to seek timely
professional advice, either because they do not understand the
significance of early signs and symptoms, or because they are ignorant
of the health implications. The course of oral Squamous cell carcinoma
is unpredictable,  but the TNM stage (T -tumor size, N-nod al
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metastasis, M-distant metastasis) of the primary tumor correlates well
with the survival rate [ 8 ] .
In general, Squamous cell carcinomas of the posterior part of the
oral cavity are more likely to metastasize to regional lymph nodes than
squamous cell carcinomas of the anterior part  of the oral  cavity [ 7 ] .
Small well -differentiated, low-grade oral Squamous cell carcinomas
usually metastasize to regional lymph nodes only after invading
connective tissue, muscle or bone. On the other hand, poorly -
differentiated, high-grade oral Squamous cell carcinomas are
biologically more aggressive and tend to metastasize to regional lymph
nodes early in the course of the disease. [ 7 ]
In the last  30 years, the 5 -year survival rate of patients with oral
Squamous cell carcinoma has not improved despite advances in
diagnostic techniques and improvements in treatment modalities.
Indeed, the incidence and prevalence of oral SCC are increasing,
particularly in younger persons [ 9 ] .
Apoptosis or Programmed Cell Death (PCD) was first  described
by Kerr et  al. (1 1 ) which are characterized by specific morphological
and biochemical changes of dying cells, including cell shrinkage,
nuclear condensation and fragmentation, dynamic membrane blebbing
and loss of adhesion to neighbors or to extracellular matrix (1 2 ) .
Biochemical changes include chromosomal DNA cleavage in to
internucleosomal fragments, phosphatidylserine externalization and a
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number of intracellular substrate cleavages by specific proteolysis (1 3 ,
1 4 )
.
Apoptosis (type I PCD) is the major type of cell death that
occurs when DNA damage is irreparable two pathways initiate
apoptosis, both of which activate the executioner caspases 3, 6, and 7.
The first pathway is the intrinsic or mitochondrial,  pathway where the
mitochondria control  the initiation of apoptosis.
Apoptotic stimuli induce the release of cytochrome c and other
apoptotic regulators from the intermembrane space of mitochondria. In
the cytosol, cytochrome c,  APAF-1, ATP, and the init iator procaspase 9
forms the apoptosome, which affects the cleavage of effectors
caspases. The Bcl-2 family of proteins regulates the mitochondrial
permeability.
The second pathway is known as the extrinsic pathway, which is
mediated by various death receptors on the cell surface. These
receptors, once activated by specif ic l igands,  initiate the recruitment of
FAS-associated death domain protein and procaspases 8 and 10 to the
death domain, which forms the death inducing signal complex and
promotes the activation of caspase 8. [ 1 5 ]
Apoptosis occurs normally during development and aging and as
a homeostatic mechanism to maintain the cell populations in tissues.
Introduction
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Apoptosis also occurs as a defense mechanism such as in immune
reactions or when cells are damaged by disease or noxious agents. (1 6 )
Although there are a wide variety of stimuli and conditions, both
physiological and pathological , that can trigger apoptosis, not all cells
will necessarily die in response to the same stimulus. Irradiation or
drugs used for cancer chemotherapy results in DNA damage of some
cells, which can lead to apoptotic death through a p53-dependent
pathway. Some hormones, such as corticosteroids, may lead to
apoptotic death of some cells (e.g. thymocytes) although other cells are
unaffected or even st imulated.
Some cells express Fas or TNF receptors that can lead to
apoptosis via ligands binding and protein cross -linking. Other cells
have a default death pathway that must be blocked by a survival factor
such as a hormone or growth factor.  There is also the issue of
distinguishing apoptosis from necrosis, two processes that can occur
independently,  sequentially,  as well  as simultaneously. (1 7 )
In some cases it’s the type of stimuli and/or the degree of stimuli
that determines the cells death by apoptosis or necrosis. At low doses,
several of injurious stimuli such as heat, radiation, hypoxia and
cytotoxic anticancer drugs can induce apoptosis but these same stimuli
can cause necrosis at higher doses. Finally,  apoptosis is a coordinated
and often energy-dependent process that  involves t he activation of a
Introduction
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group of cysteine proteases called “caspases” and a complex cascade of
events that link the initiating stimuli to the final  demise of the cell.
Caspases (cysteinalaspartate-specific proteases) are enzymes
which utilize a catalytic cysteine to cleave their peptide substrates
after specific aspartate residues. The first caspase was discovered in
1992 and because of its function was named interleukin -1-“converting
enzyme (ICE) but was later renamed to caspase -1. In 1993, Ced-3 from
C. elegans was found to be homologous to ICE and the corresponding
human protein CPP32 (later named caspase -3) was found in 1994. The
official caspase nomenclature was decided on in 1996 to alleviate the
confusion that went along with the discovery of ten differe nt caspases
(some with multiple names). (1 8 )
Caspases are divided into two main categories based on their
function: apoptotic caspases and inflammatory caspases. The apoptotic
caspases are further divided into two categories based on the time of
entry into the apoptotic cascade: init iator caspases and effector
caspases.
Introduction
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Fig1; Domain arrangement of mammalian caspases
The effectors caspases -3, -6, and -7, are found as inactive dimers
in the cell.  They are activated once an initiator caspase cleaves their
intersubunit linkers.  Because they do not require death scaffolds for
dimer formation, their prodomains are short and lack the CARD
(caspase activation and recruitment domain) or DED (death effectors
domain),   domains typical of initiator c aspases. Their prodomains are,
however, l ikely to be involved in targeting within the cell. (1 9 )
The activation of caspases commits the cell to apoptosis. The
main hallmarks of apoptosis include rounding of cells ,   retraction from
neighbors, membrane blebbing to form vesicles called apoptotic bodies,
nuclear fragmentation, chromatin condensation, hydrolysis of genomic
Introduction
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DNA to approximately 200 bp fragments, and translocation of
phosphatidylserine (PS) to the external  surface of cells as an “eat me”
signal to phagocytes.
The apoptotic caspases are necessary for conferring all of these
phenotypes.  In addition to the systematic dismantling of the cell ,
caspases are also involved in producing “find -me” signals to cause
chemo taxis of phagocytes to apoptotic cells (2 0 ) .  The recruitment of
phagocytes   keeps the cells from releasing their contents into
extracellular space and activating an immune response which could be
harmful to the tissue.
When the number of apoptotic cells is too great for con sumption
by phagocytes,  Secondary   necrosis can occur. When this happens,  the
cell releases its contents into the extracellular space. However, immune
cells are somehow able to recognize the cells undergoing   apoptosis
(and secondary necrosis) differentl y from the necrotic cells. This is
likely due to the action of caspases.  Caspases keep danger -associated
molecular patterns (DAMPs) and alarming from being activated. (2 1 )
This can be thought of as a “tolerate me” signal.
Caspases are also involved in turning off transcription and
translation. This keeps any infecting viral particles from replicating
using the host’s machinery and they also fragment the Golgi,  ER, and
mitochondria. . (2 2 ) Caspase-3 activity was found to be important for
Introduction
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differentiation of erythroblasts, skeletal  muscle, bone marrow stromal
stem cells, and neural stem cells.
Caspase-3 has several other non-apoptotic functions in nerve
cells. In addition to neural cell differentiation, caspase -3 has also been
implicated in neuronal migration and plasticity, axon pruning, and
synapse elimination .Caspases have been shown to play a role in cell
migration and invasion under certain circumstances. They can also
induce the neighboring cells to proliferate and the replace dying cells
in a process called apoptosis -induced proliferation. (2 3 ) These roles of
caspases have implications for cancer such as moderate activation of
caspases could,   cause cancer to progress rather than regress.
Caspase-3 is a member of the cysteine protease family and plays
a critical role in the regulation of programmed cell death (apoptosis).
Caspase-3 expression has been extensively studied in many cancers and
the positive correlation between its expression and a favorable
prognosis has been reported in several cancers, suggesting its  use as a
prognostic marker for cancers. In oral squamous cell carcinomas
(OSCCs), increased caspase-3 expression has been shown to inversely
correlate with cell  differentiation. (2 4 )
Aim and Objectives
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AIM AND OBJECTIVES
 To evaluate the expression of caspase 3 enzyme marker in oral
squamous cell carcinoma.
 To evaluate the expression of caspase3 enzyme marker in normal
oral mucosa.
 To compare the expression of caspase3 enzyme marker in oral
squamous cell carcinoma and normal oral mucosa.
 To aid in assessing the prognosis of the oral squamous cell
carcinoma and its adjuvant role in therapy
Materials and Methods
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MATERIALS AND METHODS
STUDY DESIGN:
A cross sectional study was performed to determine the
expression of caspase3 enzyme marker in Oral squamous cell
carcinoma tissue. These tissues were obtained from twenty (20)
patients with lesions clinically and histopathologically confirmed of
Oral squamous cell carcinoma and Five (5) healthy individuals
comprised the control group.
STUDY SUBJECTS:
Twenty (20) cases of oral squamous cell carcinoma were selected
and constituted as Group I. A predetermined clinical case sheet was
used to record all the cases and a detailed case history including age,
sex, occupation, past  medical and dental history along with the history
of habits and drugs were recorded.
This was followed by general examination and intra oral
examination. Incisional biopsy of sufficient width and depth to ensure
inclusion of connective tissue from the affected mucosa was done and
transferred to 10% buffered formalin.   Only lesions, which were
diagnosed histo pathologically as squamous cell carcinoma, were
included in the study.
Five (5) patients who reported to the outpatient department of
Oral and Maxillofacial Surgery for removal of impacted third molars
Materials and Methods
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constituted the control group Group II.   Normal buccal and gingival
mucosa adjacent to the si te of surgery was biopsied. The tissues taken
were immediately transferred to 10% buffered formalin for further
processing and after adequate fixation; paraffin blocks of the tissues
were made.
Informed consent was obtained from all the subjects enrolled in
the study and Institutions of Ethical  Committee permission was
obtained.
Materials and Methods
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IMMUNOHISTOCHEMISTRY PROCEDURE:
Armamentarium:
 Microtome
 Autoclave
 Hot air oven
 Coupling jars
 Measuring jar
 Refrigerator
 Weighing machine
 Cyclomixer
 APES coated slides [3 –Amino Propyl tri Ethoxy Silane]
 Slide carrier
 Slide warmer
 Aluminum foil
 Micropipettes
 Tooth forceps
 Electronic timer
 Beakers
 Rectangular steel trays with glass rods
 Sterile gauze
 Cover slips
 Light microscope
Materials and Methods
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Reagents for IHC
1. Conc.HCL
2. Laxbro solution
3. Acetone
4. Citrate buffer [Ph-6]
5. TRIS buffer saline [Ph 7.2-7.4]
6. 3 %(H2O2)
7. Deionized distil led water
8. Haematoxylin
9. Eosin
10. Alcohol (70%)
11. Absolute alcohol
12. Xylene
Materials and Methods
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Antibodies used:
1. Primary antibody
Monoclonal mouse anti caspase 3(Cell Signalling)
2. Secondary antibody
Citrate buffer
3. Chromogen DAB (3- Diaminobenzidine Tetra Hyrochooride)
PROCEDURE:
Pre made APES coated slides were used. Tissue section of  0.5
micron thickness were made in a rotar y semi automatic microtome and
the ribbon of tissue sections  were transferred on to the  APES [3
Amino Propyl tri –Ethoxy Silane] coated slide from  the tissue
floatation bath such that two tissue bits comes on to the slide with a
space in between. One of the tissue sections was labeled positive [P]
control and the other as negative [N] control.
IMMUNOHISTOCHEMISTRY PROCEDURE:
The slides with the tissue section were treated with three changes
of xylene to remove paraffin wax and then they were put in de scending
grades of alcohol and later rehydrated with water. Then the sl ides were
transferred to citrate buffer and autoclaved for antigen retrieval at 15
lbs pressure for 15 minutes. The slides were washed in two changes of
distilled water and were dipped in 3 changes of Tri -Phosphate buffer
saline (TBS) for 5 minutes each. The sl ides were then wiped carefully
without touching the tissue section with gauze in order to remove
excess TBS. Circles were drawn around the tissues, so that the
Materials and Methods
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antibodies added later do not spread and are restricted to the circle.
Blocking reagent was added to both the specimens and incubated for 5
minutes. The sections taken out were washed in three changes of cold
TBS for 5 minutes in each. Then the slides were wiped carefully
without touching the tissue section to remove excess TBS. The primary
antibody, CASPASE 3 Mouse Monoclonal Antibody was added to [P]
positive tissue on the slide and then TBS was added to the [N] negative
tissue. The slides were incubated for 1 hour.
The sections taken out were washed in three changes of cold
TBS for 5 minutes in each to remove the excess antibody.  Then the
slides were   wiped carefully without touching the t issue section to
remove excess TBS. Then a drop of biotnylated link from secondary
antibody kit was added on both the sections and the sl ides were
incubated for 20 minutes. Later slides were washed in three changes of
cold TBS for 5 minutes each and were wiped carefully without
touching the tissue section to remove excess TBS. Then a drop of
Streptavidin- Horse Radish Peroxidase (HRP) from the secondary
antibody kit was added on both the sections and the sl ides were
incubated for 10 minutes. The sections were washed in three changes of
cold TBS for 5 minutes in each and were wiped carefully without
touching the tissue section to remove excess TBS.
Then a drop of freshly prepared DAB (3 -Diaminobenzidine Tetra
Hydrochloride – a substrate chromogen) was added on both sections
and was then washed in running distilled water to remove excess DAB
Materials and Methods
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and counter stained with hematoxylin. The slides were placed in a tray
with tap water for bluing. Then the slides were transferred to 70%
alcohol 100% alcohol and two changes of xylene. The tissue sections
were then mounted with DPX and were then observed under the
microscope. Throughout the procedure, care was taken not to dry the
tissues.
POSITIVE CONTROL:
Tonsil carcinoma specimen tissues were fixed, processed,
embedded, sectioned and stained in the same manner and was used as a
positive control . One posit ive control tissue slide was included for
each batch of staining.
Materials and Methods
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IHC PROCEDURE FLOW CHART:
APES coated slides with 2 paraffin embedded tissues
↓
Placed in xylene thrice (5 minutes each)
↓
Placed in 100% isopropanol (5 minutes)
↓
Placed in 70% isopropanol (5 minutes)
↓
Washed in distilled water thrice (5 minutes)
↓
Placed in 3% hydrogen peroxide (20 minutes)
↓
Washed in distilled water thrice (5 minutes each)
↓
Kept in a citrate buffer   Ph 6 and then autoclaved at 21ºc with 121psi
for Antigen retrieval followed by bench cooling for 40 minutes
↓
Washed in TBS thrice (5 minutes each)
↓
Blocking reagent was added to both the specimens and then incubated
at room temperature in an enclosed hydrated container (5 minutes)
↓
Washed in TBS thrice (5 minutes each)
↓
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Primary antibody was added to the study specimen and incubated in an
enclosed hydrated container (1 hour)
↓
Washed in TBS thrice (5 minutes)
↓
Secondary antibody was added and incubated in an enclosed hydrated
container (20 minutes)
↓
Washed in TBS thrice
↓
Streptavidin HRP was added and incubated in an enclosed hydrated
container
(10 minutes)
↓
Washed in TBS thrice (5 minutes each)
↓
DAB was added and incubated in an enclosed hydrated container
(5minutes)
↓
Washed in TBS thrice (5 minutes)
↓
Stained with hematoxylin (1 minutes)
↓
Washed in running water
↓
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Placed in ammonia (1 minute)
↓
Washed in running water
↓
Placed in 70% alcohol (5 minutes)
↓
Placed in 100% alcohol (5 minute)
↓
Placed in xylene twice (5 minute each)
↓
Slides were mounted using DPX
↓
Slides were observed under Light Microscope and graded
Statistical Analysis
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STATISTICAL ANALYSIS
The Normality tests Kolmogorov-Smirnov and Shapiro-Wilks
tests results reveal that variablesdo NOT follow Normal distribution.
Therefore to analyse the data Non parametric methods are applied. To
compare values between cases and Controls Mann Whitney test is
applied. To analyse the data SPSS (IBM SPSS Statistics for Windows,
Version 22.0, Armonk, NY: IBM Corp. Released 2013) is used.
Significance level  is fixed as 5% (α = 0.05).
 Independent sample T-Test was done to compare mean values
between Groups.
 Chi-Square test to compare proportions between Cases and
Controls.
 Mann Whitney test was done to compare the staining intensity
between the Groups (epithelium and connective tissue).
Review of Literature
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REVIEW OF LITERATURE
The name caspase is short for cysteinyl aspartate -specific
protease. Caspases (cysteinal aspartate-specific proteases) are enzymes
that utilize a catalyt ic cysteine to cleave their peptide substrates after
specific aspartate residues. Caspases are the terminal proteases
involved in apoptosis, as well as being involved in inflammation. (2 5 )
The first caspase was discovered in 1992 and because of its
function it was named as interleukin -1-“converting enzyme (ICE) (2 6 ,
2 7 ) but was later renamed to caspase -1. In  1993, Ced-3 from C. elegans
was found to be homologous to ICE (2 8 ) and the corresponding human
protein CPP32 (later named caspase-3) was found in 1994 (2 9 ) .The
official caspase nomenclature was decided on in 1996 to alleviate the
confusion that went along with  the discovery of ten different caspases
and  some with multiple names.
Caspases are expressed as proenzymes (zymogens) called
procaspases, which then become activated to the mature caspase form.
Procaspase structure can be divided into three domains such as an N -
terminal prodomain, a large subunit , and a small subunit and their first
step in maturation is dimerization. Then, proteolytic processing
removes the prodomain and cleaves a loop called the intersubunit
linker between the larger and smaller subunits.
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.
Fig 2.Procaspase-3 model and crystal structure of caspase -3. Active
site loop coloring: yellowDL1, redDL2, cyanDL20, blueDL3, tanDL4
The secondary structure of mature caspases consist  of six core -
strands in a sl ightly twisted sheet in each monomer, wi th two main
helices on one face (the “front”) of the protein and three helices on the
other face (the “back”) of the protein (Fig 2). The first  four core
strands and helices 1–3 form the large subunit, whereas the last two
core strands and helices 4–5 form the smaller subunit.  The dimer
interface consists of the final strand from each monomer, side by side
in an anti parallel manner. The two monomers are related through a C2
axis of symmetry such that one monomer is “upside -down” compared to
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the other monomer. Five loops are important for the formation of the
active site and once the intersubunit linker is cleaved, the two halves
of the cleaved linker are called L2 and L20. Active site loops L1, L2,
L3, and L4 come from one monomer, and loop L20 comes from t he
other. The catalytic cysteine is a part of loop L2, while the catalytic
histidine is  part of a loop extending from the C terminal end of 3. (1 8 )
Caspases are not only required for apoptosis, but it  also be required for
regulating non apoptotic functions in certain cell  types. (3 0 )
.
Pei-Feng Liu et al conducted a study for   the expression levels of
cleaved caspase-3, caspase-8, and caspase-9 on tissue microarrays
consisting of samples from 246 oral squamous cell carcinoma (OSCC)
patients (tongue) by    immunohistochemistry.  The protein levels o f
cleaved caspase-3, caspase-8, and caspase-9 in tumor tissues were
significantly higher when compared to those in adjacent normal tissues
(all p<0.001).
The expression levels of caspase -8 in tumors were elevated in
patients with lymph node invasion and moreover,  positive expression
of cleaved caspase-3 was associated with shorter disease-free survival
(DFS) in OTSCC patients with moderate differentiation a nd lymph
node invasion. Combination of either positively cleaved caspase -3 or
higher caspase-3 expression or both was associated with poor DFS.
They concluded that co-expression level of cleaved caspase-3 and
caspase-3 might be a prognostic biomarker for OTSCC patients,
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particular in those patients with certain tumor stages and cell
differentiation status. (3 1 )
Huang et al. Evaluated caspase 3 expressions by
immunohistochemical analysis in two cohorts of human cancer patients,
in which the first cohort, included 39 head and neck cancer patients
treated with radiotherapy or chemo-radiotherapy while the second
cohort included 48 advanced stage breast cancer patients.  Results
showed   higher cleaved (activated) caspase 3 levels in the tumor
samples and a higher rate of tumor recurrence; hence they concluded
that elevated caspase 3 levels were seen in cancer patients. (3 2 ) .
Ana Flavia et al conducted  a retrospective study in    120 patients
which  included  20 oral leukoplakia  cases (16 with and 4 without
dysplasia)   20  actinic chelitis cases( 15 with and 5 without dysplasia)
40 oral  squamous cell carcinoma  cases ( 20 intraoral squamous cell
carcinomas and 20 lower lip Squamous cell carcinomas) and  40
inflammatory fibrous hyperplasia  cases  (20 intra o ral inflammatory
fibrous hyper  plasia  and 20 lower lip inflammatory fibrous
hyperplasia)   by immunohistochemical analysis with anticleaved
caspase-3 antibody.  Their results showed that  cleaved caspase 3 levels
were higher in intra oral Squamous cell ca rcinomas .Hence they
concluded that  caspase 3 levels were elevated in oral squamous cell
carcinoma. (3 3 )
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Shuxia LI,Yanqi et al  conducted  a  study  to investigate the impact
of survivin and caspase-3 on apoptosis and angiogenesis in  oral cancer
patients, which  included  a total of 16 oral leukoplakia cases of
moderate epithelial dysplasia, 12  oral  leukoplakia cases of severe
epithelial dysplasia, 17 cases of moderately differentiated oral
squamous cell carcinoma and 10 cases of normal oral  mucosa.
Immunohistochemical analysis was done to detect the expression levels
of survivin, caspase-3, and caspase inhibitor factor VIII in lesions from
each group and they revealed an increased expression level of survivin
in oral  cancer tissues when compared with the normal mucosa and also
concluded that the expression of Caspase -3 was decreased during
malignant transformation. (3 4 )
Janakiraman etal conducted a study on   RNA-binding protein Hu
Antigen-R (HuR) that controls post -transcriptional gene regulation and
undergoes stress-activated caspase-3 dependent cleavage in cancer
cells. They said that the   Caspases are defined as either tumor
suppressors or oncogenes by executing cell death in normal cells or by
undergoing severe suppression in some cancers cells and t he Absence
of caspase-3 was reported in multiple cancers including breast cancer,
hepatocellular and prostate carcinomas. In addition to that , inactive
caspase-3 was reported in both oral carcinomas and normal oral
epithelial  tissues and their results clea rly showed that over expressed
COX-2 inhibits the cleavage of caspase-3 and HuR in oral cancer
cells. (3 5 )
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Hague A et al Conducted a study to determine alteration of caspase -3
expression during oral carcinogenesis.Caspase -3 expression in normal
oral epithelium and oral squamous cell carcinoma were compared by
including   39 samples of normal oral  epithelium and 54 oral squamous
cell carcinomas in their study and   the results showed that   Squamous
cell carcinomas had more intense caspase -3 staining than normal
epithelium. In the oral squamous cell  carcinoma series, there was
significantly more intense caspase 3 expression in nuclear and
cytoplasmic staining with increasing STNMP stage. (3 6 )
Coutinho-Camillo et al conducted  a research  study to analyze the
expression profiles of 23 proteins that have been linked to the
inhibit ion (Bcl-2,  Bcl-x, Bcl-xL, Bcl-2-related protein A1, BAG-1, and
survivin) and promotion (Bak, Bax, Bim/Bod, Bim -Long, Bad, Bid,
PUMA, Apaf-1, caspase-2, caspase-3, caspase-6, caspase-7, caspase-8,
caspase-9, caspase-10, Smac/DIABLO, and cytochrome c) of apoptosis
in oral squamous cell carcinoma and they include Two -hundred and
twenty nine cases of oral squamous cell carcinoma, by using
immunohistochemical   method analysis, results were quantified on an
automated imaging system and their results showed that the caspase-3
was expressed higher in squamous cell carcinoma and it was correlated
with lymphnode metastasis . . (3 7 )
Liang Pang et al evaluated the decreased mRNA expression of
caspase-3, caspase-8 and caspase-9 in   Human Oral Squamous Cell
Carcinoma (HSC-3) oral cancer cells were analyzed by RT -PCR and
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Western blot assays. After ursodeoxycholic acid (UDCA) treatment, the
mRNA and protein expression of caspase-3, caspase-8 and caspase-9
were increased compare to the control  cells, and these changes were
increased in a concentration-dependent manner. (3 8 )
Poomsawat et al investigated  the expression  of survivin  and caspase
3 in 114 samples including oral squamous cell carcinoma, oral
leukoplakia( with and without dysplasia) and normal oral  mucosa   and
were immunohisto chemically analyzed   and  their results showed that
the numbers of cytoplasmic  and  nuclear expression of caspase 3 in
OSCC were significantly higher than that of normal mucosa and  oral
leukoplakia (with and without dysplasia) so they concluded that
elevated expression of caspase 3 in oral squamous cell carcinoma
indicates the advanced stage of oral cancer. (3 9 )
Nagaraj et al conducted a research study on hypoxia mediated
apoptosis in oral squamous cell carcinoma and showed that oral cancer
cells from primary tumors and lymph node metastasis undergo
apoptosis after 24 to 48 hours of hypoxia. He also reveal ed that during
hypoxic growth, an increase in the caspase -3 proteolytic activity
accompanied by the cleavage of PARP (poly ADP -ribose. polymerase)
was observed in oral  squamous cell carcinoma. (4 0 )
Veeran varmal et al conducted a study in 112 samples which included
15 normal tissues and 97 diseased tissues (oral sub mucous fibrosis and
oral squamous cell carcinoma associated with oral  sub mucous fibrosis)
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by immunohistochemical analysis using caspase 3 antibody. The
percentage of positive cells were calculated using Image J software and
the result showed that caspase‑3 expression epithelial cells ranged
from 11% to 38% in the normal oral mucosa  and  0 -8% in the oral
squamous cell  carcinoma,  and hence they concluded  t hat  the
decreased expression of caspase -3 in disease progression reflects its
role in the malignant transformation. (4 1 )
D  Andresskis et al investigated caspase-3 and caspase-8 protein
expression in 87 cases of primary tongue squamous cell carcinoma by
immunohistochemical analysis and digital imaging analysis assay.
Their results showed that   expressions of caspase -3 proteins were
observed 79 samples (90.5 %). (4 2 )
Antonio Bascones –Martinez et al conducted a research study for the
expression of p53, caspase-3 Bcl-2, and ki-67 in premalignant oral
epithelium and to study i ts clonal behavior 41tumors samples with their
adjacent non-tumor epithelia were analyzed by immunohistochemical
using monoclonal antibodies that recognize p53, caspase -3, Bcl-2, and
Ki-67 and they showed statistically significant expression of caspase 3
in tumors and its adjacent area (4 3 )
SX  Li et al was conducted  a  research study  to investigate the
expression of  survivin and caspase 3 in oral  squamous cell carcinoma
and peritumoral tissues,  by using ELISA and Western blot method
which included 13 tumor samples, 13 peritumoral tissue of oral
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squamous cell carcinoma  and 10 normal tissue samples. Their   results
showed that no difference in expression of caspase 3 in peritumoral
tissues and normal tissues, but it  was evidently decreased in carcinoma
tissues. (4 4 )
M.V.Fiandalo et al found that during tumor genesis, significant loss or
inactivation of caspase leads to impaired apoptosis induction, thereby
causing a dramatic imbalance in the growth dynamics and hence
resulting in aberrant growth of human cancers . (4 5 )
Andrej Cör et al conducted a study, in 28 Head and Neck Squamous
Cell Carcinoma (HNSCC) by immunohistochemical analysis and their
results showed   Pro-caspase 3 expression reduced in Head and Neck
Squamous Cell Carcinoma . (4 6 )
Atsushi Kurabayashi et al conducted a study in 76 esophageal
squamous cell carcinoma  by immunohistochemical  analys is and their
results showed that  expression of   caspase 3  was significantly
associated with poor prognosis . (4 7 )
Qian Hu et al, conducted a study by using immunohistochemical
analysis, to observe the expression of cleaved caspase -3 in 367 human
tumor samples (gastric cancer: 97 cases, ovarian cancer:  65 cases,
cervical  cancer: 104 cases; colorectal  cancer:  101 cases) and they
found that the patients with increased expression of cleaved caspase -3
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had a significant shorter overall survival time when com pared with
decreased levels of expression . (4 8 )
Heshiki et al conducted a research study for caspase 3 expressions in
30 patients who had received surgical treatment between April  2007
and March 2014. They included the primary carcinoma sites such as
the tongue (n=10), maxillary gingiva (n=6), mandibular gingiva (n=5),
floor of the mouth (n=3), and buccal mucosa (n=6) and their results
showed that all the cases of oral  squamous cell carcinomas
demonstrated a posit ive expression of cleaved caspase -3. (4 9 )
Manisha Shrivastava et al conducted a prospective pilot study based
upon the expression of XIAP and caspase 3 proteins in 11s samples of
oral squamous cell carcinoma. The results showed  amplification of
caspase-3   in 7 pure DNA samples and hence they  concluded that  the
oral cancer cells  could be recognized by expression of caspase 3  as
well as  it may have a  further  role in future target therapy in oral
cancer patients. (5 0 )
M  Olsson et al review of primary breast  tumor samples obtained from
patients undergoing breast surgery found that in approximatel75% of
the tumors as well  as morphologically normal peritumoral tissue
samples, caspase-3 transcripts and caspase-3 protein expression were
lacking. (5 1 )
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Reiner et al studied the expression of caspase -3 in knockout mice, and
concluded that a caspase is functionally deleted in a cancer cell l ine
while it is also required for certain distinctive biochemical and
morphological changes during apoptosis . ( 5 2 )
Ding YP et al conducted a study for the expression of surviving and
caspase-3 in 17 oral squamous cell carcinoma (OSCC), 28 oral
leukoplakia with dysplasia and 10 normal oral mucosa cases .The
results showed that Caspase-3 was expressed in all the normal mucosa
samples but it  was obviously down-regulated in dysplasia and oral
squamous cell carcinoma. (5 3 )
Abdel et al conducted a  study   in  25 lesional biopsy specimens,
which  included 15 Cutaneous Lichen Planus (CLP) , 10 Oral Lichen
Planus (OLP)] and 10 control specimens [5 normal skin and 5 normal
oral mucosa]  by immunohistochemical analysis  which revealed an
increase caspase-3  protein expression in  lichen planus lesions. (5 4 )
Jer –shyung  huang et al conducted  a  study  to evaluated  caspase-3
expression in tumor genesis and  its prognosis in 185  buccal mucosa
squamous cell carcinoma  patients by immunohistochemical   staining
and their results showed  that the expression levels of cleaved caspase -
3  in 185  buccal mucosa squamous cell carcinoma  tissues were
significantly higher  when compared to those in the tumor adjacent
normal tissues . (5 5 )
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Yu-Xia zhang et al conducted a  study  for cell viability of  tongue
squamous cell carcinoma  after the treatment of staurosporine, and
their results showed  that  after treatment a time -dependent reduction
of survivin and an activation of caspase-3 were observed. (5 6 )
Zarin Zainul etal analyzed the expression of caspase 3,7,8,9 and 10
in oral squamous cell carcinoma  b y tissue micro array and their result
showed that caspase 8 and 9 were  prominently expressed while
caspase 3,7and 10expressed causally. (5 7 )
Tetsu shimane et al conducted  a  study in 119  oral  squamous cell
carcinoma  cases  by using immunohistochemical analysis , their
results showed  that  apoptosis associated speck like protein appear in
well differentiated  cancer cells . (5 8 )
Mutsuko Mukai et al conducted a study, in his study results showed
that caspase-3 activation contributes to the stress-induced invasive
capacity of these cancer cells. (5 9 )
EA Slee et al showed in their review that  the cells deficient in caspase -
3 (either from CASP-3 null mice or due to a frame shift mutation, i .e.
MCF-7 cells) clearly died in response to many p ro-apoptotic stimuli. (6 0 )
Claudia Malherios Coutinho-Camilo et al conducted a study in 229
tissues of oral  squamous cell carcinoma by immunohistochemical
analysis and their results showed   that caspase 3 was expressed
occasionally. (6 1 )
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Eswaran Devarajan et al conducted a study for the caspase 3
expressions in primary breast tumor samples and normal breast
parenchyma samples by reverse transcriptase -polymerase, western blot
and northern blot analysis and they found that  75% of the tumor and
normal peritumoral t issues lacked caspase3 protein expression. Hence
their results suggested that  the loss of caspase3 expression represents
an important role in the survival mechanism of breast cancer. ( 6 2 )
Yuan –Feng Lin etal found in his research study that the Caspase-3
down regulation (CASP3/DR) in tumors conferred resistance to cancer
therapy and was significantly correlated with a poor prognosis in
cancer patients. (6 3 )
Richard Jager et al in his reviewed that the caspase -3 was detected
less in colon and stomach cancer, Non -Hodgkin lymphoma (NHL), and
hepatocellular carcinoma and while it  was elevated in acute
myelogenous leukemia (AML) breast  and prostate carcinoma. Hence
they concluded that the expression increased with tumor
progression. (6 4 )
Pieter de Heer Elza et al  conducted a randomized clinical  trial  on
pre operated rectal  biopsies  and  found that  caspase 3 activity  was
significantly lower than the normal tissue and  hence they concluded
that caspase 3 activity  was an important denominator for local
recurrence. (6 5 )
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J.Kania etal conducted a study in gastric cancer, and they found that
caspase 3 protein expression was undetectable in gastric cancer tissues
when compare to normal mucosa. (6 6 )
Ulla Toramen etal conducted a study to evaluate the caspase 3 level in
non small cell lung carcinoma and they found that caspase expression
was seen in tumors t issues and its appearance was not associated with
apoptosis. (6 7 )
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RESULTS
A total of 25 patients were included in this study, comprising of
2 groups. Group I was the study group of 20 histologically confirmed
oral squamous cell carcinoma patients. Group 2 was made of 5 normal
patients whose gingival tissues were studied.
Age distribution in study groups
In Group I .age distribution among the patients ranged between
25 to 75 years with mean age of 55.60 yrs .In Group II, age ranged
from 27 to 30 years with mean age of 25.60 yrs.(Table 1,G raph 1)
Gender distribution in study groups
Out of 20 patients in Group I consists of 15 were males and 5
were females with a male:female ratio of  3:1. In Group II,  3 were
males and 2 were females,  with a male:female ratio of 3:2 .  (Table 2,
Graph 2)
Site of biopsy in study groups
In Group I, biopsies were taken from buccal mucosa for 12
patients, alveolus or gingival for 4patients, from the tongue for 4
patients. In Group II all samples were taken from the gingival. (Table
3, Graph 3)
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Comparison of intensity of expression of Caspase3 in between
epithelium and connective tissue of Group 1 and Group 2
Epithelium:
Group 1 – Out of the 20 tissue samples, 7 (35%) showed mild staining
intensity,  4 (20%) showed moderate intensity and 6 (30%) showed
more intensity.  Epithelial expression was not seen in 3 (15%) tissue
samples.
Group 2 – Out of 5 tissue samples, 1(20%) sample showed mild
epithelial  staining and 4(80%) tissue samples was no t showed any
staining.
The difference in epithelial staining was statistically significant
between Group 1 and Group 2
(P-0.046)(Table 4,Graph 4)
Connective tissue:
Group 1 – out of the 20 tissue samples,9(45%) tissue samples showed
mild expression,3(15%) tissue samples showed moderate expression
and 1(5%) tissue showed more intensity in staining. No expression was
seen in 7 (35%) tissue samples.
Group 2 – No expression was seen in 5 t issue samples.
The difference in connective tissue sta ining was significantly between
Group 1 and Group 2
(P-0.087) (Table 5, Graph 5)
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Mann-Whitney Test to compare Epithelium grading between Cases
and Controls:
To compare the staining intensity of epithelium in between oral
squamous cell carcinoma and normal mucosa Mann –Whitney test was
performed. The p value for epithelium grading was < 0.008 which was
highly statistically significant. (Table6, Graph6)
Mann-Whitney Test to compare Connective tissue grading between
Cases and Controls:
To compare the staining intensity of Connective tissue in
between oral squamous cell carcinoma and normal mucosa Mann –
Whitney test was performed. The p value for Connective tissue grading
was ˂0.016 which was highly stat istically significant. (Table7, Graph7)
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TABLES AND GRAPHS
TABLE 1: AGE DISTRIBUTION BETWEEN GROUP1 AND
GROUP2
Group N Mean Age Std. Dev p-Value
Case 20 55.60 12.098
<0.001
Control 5 25.60 2.793
TABLE 1: AGE DISTRIBUTION BETWEEN GROUP1 AND
GROUP2
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TABLE 2: GENDER DISTRIBUTION BETWEEN THE TWO
STUDY GROUPS
Gender
Group
p-ValueCase Control Total
N % N % N %
Female 5 25.0% 2 40.0% 7 28.0%
0.597Male 15 75.0% 3 60.0% 18 72.0%
Total 20 100.0% 5 100.0% 25 100.0%
GRAPH 2: GENDER DISTRIBUTION BETWEEN THE TWO
STUDY GROUPS
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TABLE 3: SITE OF BIOPSY IN THE STUDY GROUPS
Site of biopsy
Group
p-ValueCase Control Total
N % N % N %
Buccal Mucosa 10 50.0% 0 0.0% 10 40.0%
0.012
Floor of Mouth 2 10.0% 0 0.0% 2 8.0%
Gingiva 4 20.0% 5 100.0% 9 36.0%
Tongue 4 20.0% 0 0.0% 4 16.0%
Total 20 100.0% 5 100.0% 25 100.0%
GRAPH 3: SITE OF BIOPSY IN THE STUDY GROUPS
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TABLE4: DISTRIBUTION OF EPITHELIUM INTENSITY OF
STAIN IN GROUP1 AND GROUP2
Epithelium
intensity
Group
p-ValueCase Control Total
N % N % N %
INTENSE 6 30.0% 0 0.0% 6 24.0%
0.046
MILD 7 35.0% 1 20.0% 8 32.0%
MODERATE 4 20.0% 0 0.0% 4 16.0%
NOSTAIN 3 15.0% 4 80.0% 7 28.0%
Total 20 100.0% 5 100.0% 25 100.0%
GRAPH 4: DISTRIBUTION OF EPITHELIUM INTENSITY OF
STAIN IN GROUP1 AND GROUP2
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TABLE 5: DISTRIBUTION OF CONNECTIVE TISSUE
INTENSITY OF STAIN IN GROUP1 AND GROUP2
Connective
tissue intensity
Group
p-ValueCase Control Total
N % N % N %
INTENSE 1 5.0% 0 0.0% 1 4.0%
0.087
MILD 9 45.0% 0 0.0% 9 36.0%
MODERATE 3 15.0% 0 0.0% 3 12.0%
NOSTAIN 7 35.0% 5 100.0% 12 48.0%
Total 20 100.0% 5 100.0% 25 100.0%
GRAPH 5: DISTRIBUTION OF CONNECTIVE TISSUE
INTENSITY OF STAIN IN GROUP 1 AND GROUP 2
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TABLE 6: DESCRIPTIVE STATISTICS FOR EPITHELIUM
GRADING
Group
Case Control
Epithelium Grading N 20 5
Mean 1.650 .200
Std. Dev 1.089 .447
Median 1.5 .0
1st Quartile 1.0 .0
3rd Quartile 3.0 .0
MANN-WHITNEY TEST TO COMPARE EPITHELIUM GRADING
BETWEEN CASES AND CONTROLS
Variable Group N Mean Rank P-Value
Epithelium Grading Case 20 14.88 0.008
(Sig)Control 5 5.50
GRAPH 6: COMPARING EPITHELIUM GRADING BETWEEN
CASES AND CONTROLS
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TABLE 7: DESCRIPTIVE STATISTICS FOR CONNECTIVE
TISSUE GRADING
Group
Case Control
Connective tissue
Grading
N 20 5
Mean .900 .000
Std. Dev .852 .000
Median 1.0 .0
1st Quartile .0 .0
3rd Quartile 1.0 .0
MANN-WHITNEY TEST TO COMPARE CONNECTIVE TISSUE
GRADING BETWEEN CASES AND CONTROLS
Variable Group N
Mean
Rank
P-Value
Connective tissue
Grading
Case 20 14.63
0.016 (Sig)
Control 5 6.50
GRAPH7: COMPARING CONNECTIVE TISSUE GRADING
BETWEEN CASES AND CONTROLS
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PHOTOGRAPHS
POSITIVE CONTROL
Figure 3: Tonsil: H & E: 10 x
Figure 6: Tonsil: Caspase 3 stain: 10 x
Figure 7: Tonsil: Caspase 3 stain: 40x
Photographs
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ORAL SQUAMOUS CELL CARCINOMA
Figure 8: H & E: 10x
Figure 9: Caspase 3 stain 10 x
Figure 10: Caspase 3 stain 40 x
Photographs
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ORAL  SQUAMOUS CELL CARCINOMA
Figure 11: H & E stain:10x
Figure 12: Caspase 3 stain: 10 x
Figure 13: Caspase 3stain:40 x
Photographs
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ORAL SQUAMOUS CELL CARCINOMA
Figure 14: H & E stain: 10 x
Figure15: Caspase 3 stain:10 x
Figure 16: Caspase 3 stain :40 x
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Fig 1: Oral Squamous Cell Carcinoma in the Alveolar Mucosa
Fig 2: Oral Squamous Cell Carcinoma in the Buccal Mucosa
Discussion
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DISCUSSION
World 6 t h most common cancer is  Oral Squamous Cell
Carcinoma. In India oral cancer ranks first among all the cancers in
males and it is the third most common cancer in females. (6 8 ) In head
and neck region squamous cell carcinoma is the commonest type which
has increased in the recent year. (6 9 )
Oral squamous cell carcinoma is a multi  factorial disease which
is associated with tobacco chewing, alcohol,  smoking, ultra violet
radiation, human papilloma virus, candidal infection, nutritional
deficiencies and genetic pre disposition. (7 0 ) Oral squamous cell
carcinoma is more common in the later decades of the life, with
increased risk as the age advances.
Approximately 94%  of oral cancers are squamous cell
carcinoma. (7 1 ) our present study had  patients of age group between
the 4 t h and 5 t h decades of  life which was similar to studies of Fábio
Ramôa PIRES et al, Mahindra Pratap singh et al, Preeti Sharma et al, R
Shenoi et al,  and Juliana Hintz Germanos Scheidt et al . (7 0 ,7 2 ,73 ,7 7 ,8 2 )
Takuji Tanaka et al and Liviu Feller et al in their studies they pointed
out that  oral squamous cell carcinoma occurs  under 40years and 45
years respectively (7 5 ,6 8 )
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Oral squamous cell  carcinoma shows male predilection with a
male to female ratio of 3:1. In our present study males were 75% and
females were 25% with a female and male ratio of 3:1, which was
consistent with the below cited reports where Liviu Feller et  al, Fábio
Ramôa PIRES et al , and Arvind Krishamurthy et al , in their studies
pointed out that males were affected more commonly when  compared
to females,  because of  indulgence into more habits (6 8 ,  7 0 ,  7 4 ).
Juliana Hintz Germanos Scheidt et al pointed out in his study
that, among the persons  who do not smoke and  consume alcohol,
women were affected most commonly in relation  to increasing  age
when compared to  men, because of  the alteration of the choromogenic
pattern. (8 2 )
Arvind Krishnamurthy et  al , Takuji Tanaka et al, and R.Shenoi et
al in their studies showed that tobacco, betel quid and alcohol were the
major carcinogens for the occurrence of oral squamous cell carcinoma .
(7 4 ,  7 5 ,  7 7 )
. Takuji Tanaka et al also showed in their studies  that human
papilloma virus particularly HPV type 16 was an etiological factor,
especially among persons who do not smoke or consume alcohol. (7 5 )
Brad W.Neville et al stated that  heavy smoking ,heavy alcohol
usage, using  tobacco, betel leaf  with betel nut and slacked lime were
the important etiological factors  for the development of oral squamous
cell carcinoma in India. (7 6 ) Similar observations  were reported in our
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present study, as most of the patients were smokers, alcoholics  and
pan chewers.
The most common sites of oral squamous cell carcinoma are
tongue, floor of the mouth, hard palate, buccal mucosa, labial mucosa
and retro molar area.
In our presnt  study ,the most of the cases of oral squamous cell
carcinoma were seen in the buccal mucosa, which was similar to the
studies of  Preethi Sharma et al and Vaidhehi narayan nayak et al. (7 3 ,7 9 )
In contrast to our present  study, R Shenoi et al and  Antoniades et  al
showed that, the mandibular a lveolus and lip were the common sites
respectively, (7 7 ,7 8 ) while Arvind Krishnamurthy et al,  Juliana Hintz
Germanos Scheidt et  al and Liviu Feller et al showed in their study that
the common site was tongue . (7 4 ,8 2 ,6 8 )
Pindborg et al classified oral squamous cell   carcinoma
microscopically based on the degree of keratinization, cellular and
nuclear pleomorphism and mitotic activity.  The grades are well
differentiated (grade 1), moderately differentiated (grade 2) and poorly
differentiated (grade 3).  Our present study includes all categories of
well, moderately and  poorly differentiated oral squamous cell
carcinoma cases. (8 0 )
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In our present study, we used Immunohistochemical methods to
analyse caspase 3 expression in  oral squamous cell carcinoma, which
was similar to the methods used by  Claudia Malheiros Coutinho -
Camillo et al, Shuxia et  al , Sopee Poomsawat et  al , Ana Flavia
Schueler de Assumpcao  et al and Pei -Feng Liu et al  in their
studies. (3 1 ,3 3 ,3 4 ,39 ,6 1 ) In contrast to our study Sx li et al  used ELISA and
Western blot method (4 4 ) while Wataru Heshiki et al  and Eswaran
Devarajan et al   included  Immunohisto chemical analysis along with
cell line culture and flow cytometry method to analyse caspase 3
expression. (4 9 ,6 2 )
Caspase3 expression was seen as a brown end reaction in both
cytoplasm and nucleus. In  our  present study, caspase 3 was expressed
in the epithelium and connective tissue with varying degrees and was
absent in most of the normal oral  mucosa, which was similar to the
studies done by Claudia Malheiros Coutinho -Camillo et al and Shuxia
et al where they observed caspase 3expression in the cytoplasm of oral
squamous cell carcinoma at  varying  degrees and absence in the normal
mucosa. (3 4 ,3 9 )
Ana Flavia Schueler de Assumpcao  et al ,  Pei -Feng Liu et  al,
Hague et al and D Andressakis et al  observed in their studies that the
caspase 3expression was significantly higher in oral  squamous cell
carcinoma  when compared to the normal mucosa. (3 3 ,3 9 ,3 6 ,4 2 ) while Qian
Hu et al, Andrej cor et al  and Vakkala M et al  also observed in their
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studies that the caspase 3 expression was higher in gastric cancer, head
& neck cancer and  breast cancer  when compared  to the normal
tissues respectively. (4 8 ,4 6 ,8 1 ) Hence these findings indicate that
decreased caspase 3 expression was associated with advanced clinical
staging of the disease.
In contrast to our present study, Veeranvermal et al showed that
the caspase3 expression was significantly lower in oral squamous cell
carcinoma tissues when compared to the normal mucosa which was
possibly due to the inhibit ion of caspase 3 synthesis by survivin, and
this process lead to the development of oral squamous cell carcinoma
by prevention of apoptosis. (4 1 )
In our present study,  expression of caspase 3 antigen was seen in
oral squamous cell carcinoma tissues of both epithelium and connective
tissue. In  the oral  squamous cell   carcinoma group of  20 cases
epithelium   showed 85% of caspase 3 expressions whil e connective
tissue showed 65% caspase3 expression. In control group, epithelium
showed 20% caspase3 expression and  the connective tissue showed
negativity.
Summary and Conclusion
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SUMMARY AND CONCLUSION
A total of 25 patients were included in our study, comprising of
20 patients of oral  squamous cell carcinoma and 5 normal controls.
 In our study,the mean age of the patients with oral squamous cell
carcinoma was 55.60 years ± 12.098 whereas for control group the
mean age was 25.60 ± 2.793
 Our study comprised of  15 males and 5 females in oral squamous
cell carcinoma, 3 males and 2 females in normal group.
 The site of biopsy in Oral Squamous Cell  Carcinoma was the buccal
mucosa(50%), tongue (20%), gingival (20%)and floor of the mouth
(10%). In Normal mucosa tissues were obtained from gingiva.
 Immunohischemical study was done to demonstrate the expression
of caspase 3 enzyme marker in oral squamous cell carcinoma and
normal mucosa by using Monoclonal mouse anti caspase 3.
 Caspase 3enzyme marker expression in epithelium and connective
tissue was higher in Oral Squamous Cell Carcinoma when compare
to Normal tissue. The results were statist ically significant .
The results of our  present study demonstrated that increased
caspase 3expression was seen in oral squamous cell carcinoma tissues
than that of the normal mucosa.  These findings indicate the caspase 3
expression response to prognosis of   the cancer and this has to be
explored in a larger sample for further studies.
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